This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio
Job Summary
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio.
The role requires designing comprehensive patient access plans and navigating complex reimbursement processes with key stakeholders like ZIN and the Ministry of Health.
Candidates will receive a competitive salary, 3% year-end bonus, 35.5 days of leave, and a company car as part of the benefits package.
Matching Summary
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio.
Salary
Competitive salary; 3% year-end bonus; Company car included
Skills & Requirements
Must-have
7+ years pharmaceutical market access experience
In-depth Dutch healthcare system knowledge
ZIN and cieBAG reimbursement procedures expertise
Health economics and HTA experience
Functional leadership of cross-functional teams
Fluency in Dutch and English languages
Nice-to-have
Strong strategic thinking and analytical skills
Proven negotiation and relationship building
Experience with cardiovascular or non-oncology portfolios
Ability to navigate complex organizational networks
Background in Real World Evidence (RWE)
Key Requirements
University degree in health economics, pharmacy, or life sciences
Minimum 7 years of experience in pharmaceutical market access